BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 16713038)

  • 41. [Varicella vaccine].
    Abarca Villaseca K
    Rev Chilena Infectol; 2006 Mar; 23(1):56-9. PubMed ID: 16462966
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A review of varicella vaccine and Louisiana vaccination requirements.
    Buff AM; Welch FJ; Tapia RA
    J La State Med Soc; 2004; 156(1):50-5. PubMed ID: 15000215
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine 2-dose varicella immunization schedule.
    American Academy of Pediatrics Committee on Infectious Diseases
    Pediatrics; 2007 Jul; 120(1):221-31. PubMed ID: 17606582
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epidemiology of Breakthrough Varicella after the Implementation of a Universal Varicella Vaccination Program in Taiwan, 2004-2014.
    Cheng HY; Chang LY; Lu CY; Huang LM
    Sci Rep; 2018 Nov; 8(1):17192. PubMed ID: 30464186
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Varicella vaccination update].
    Nürnberg W; Schneeweiss B
    J Dtsch Dermatol Ges; 2006 Jul; 4(7):540-3. PubMed ID: 16827911
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A decline in varicella but an uncertain impact on zoster following varicella vaccination in Victoria, Australia.
    Carville KS; Riddell MA; Kelly HA
    Vaccine; 2010 Mar; 28(13):2532-8. PubMed ID: 20117265
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidemiological characteristics of varicella from 2000 to 2008 and the impact of nationwide immunization in Taiwan.
    Chang LY; Huang LM; Chang IS; Tsai FY
    BMC Infect Dis; 2011 Dec; 11():352. PubMed ID: 22176638
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Varicella vaccination in Japan, South Korea, and Europe.
    Sadzot-Delvaux C; Rentier B; Wutzler P; Asano Y; Suga S; Yoshikawa T; Plotkin SA
    J Infect Dis; 2008 Mar; 197 Suppl 2():S185-90. PubMed ID: 18419395
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Varicella disease among vaccinated persons: clinical and epidemiological characteristics, 1997-2005.
    Chaves SS; Zhang J; Civen R; Watson BM; Carbajal T; Perella D; Seward JF
    J Infect Dis; 2008 Mar; 197 Suppl 2():S127-31. PubMed ID: 18419385
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chickenpox complications in Saudi Arabia: Is it time for routine varicella vaccination?
    Almuneef M; Memish ZA; Balkhy HH; Alotaibi B; Helmy M
    Int J Infect Dis; 2006 Mar; 10(2):156-61. PubMed ID: 16260166
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Should children with inherited metabolic disorders receive varicella vaccination?
    Varghese M; Cafferkey M; O'Regan M; Monavari AA; Treacy EP
    Arch Dis Child; 2011 Jan; 96(1):99-100. PubMed ID: 19846994
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The burden of varicella and zoster in British Columbia 1994-2003: baseline assessment prior to universal vaccination.
    Edgar BL; Galanis E; Kay C; Skowronski D; Naus M; Patrick D
    Can Commun Dis Rep; 2007 Nov; 33(11):1-15. PubMed ID: 18163240
    [No Abstract]   [Full Text] [Related]  

  • 53. Cost-effectiveness analysis of universal childhood vaccination against varicella in Brazil.
    Valentim J; Sartori AM; de Soárez PC; Amaku M; Azevedo RS; Novaes HM
    Vaccine; 2008 Nov; 26(49):6281-91. PubMed ID: 18674582
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Near elimination of varicella deaths in the US after implementation of the vaccination program.
    Marin M; Zhang JX; Seward JF
    Pediatrics; 2011 Aug; 128(2):214-20. PubMed ID: 21788222
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Complications of varicella infection in children in southern Taiwan.
    Chi CY; Wang SM; Lin HC; Liu CC
    J Microbiol Immunol Infect; 2006 Oct; 39(5):402-7. PubMed ID: 17066203
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Varicella surveillance practices--United States, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2006 Oct; 55(41):1126-9. PubMed ID: 17060900
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Immunization Monitoring Program-active (IMPACT) prospective surveillance of varicella zoster infections among hospitalized Canadian Children: 1991-1996.
    Law B; Scheifele D; MacDonald N; Halperin S; Déry P; Jadavji T; Lebel M; Mills E; Morris R; Vaudry W; Gold R; Marchessault V; Duclos P
    Can Commun Dis Rep; 2000 Aug; 26(15):125-31. PubMed ID: 10946445
    [No Abstract]   [Full Text] [Related]  

  • 58. [Chickenpox: sufficient reasons for the introduction of vaccination].
    Rümke H; de Groot R
    Ned Tijdschr Geneeskd; 2006 Dec; 150(48):2630-2. PubMed ID: 17205937
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The impact of the varicella vaccination program on herpes zoster epidemiology in the United States: a review.
    Reynolds MA; Chaves SS; Harpaz R; Lopez AS; Seward JF
    J Infect Dis; 2008 Mar; 197 Suppl 2():S224-7. PubMed ID: 18419401
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Is Europe ready to embrace a policy of universal varicella vaccination?
    Ramet J; Weil-Olivier C; Sedlak W;
    Int J Clin Pract; 2005 Nov; 59(11):1326-33. PubMed ID: 16236088
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.